Moreover, the dose-dependent decrease in RAC activation downstream of phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) provides a biochemical link between RAS and RAC in leukemia cells. The gene discussed is AKT1; the disease is leukemia.